Such blockade of TSLP strongly downregulated pulmonary levels of IL-9 (Figure 3B) and collagen indicative of attenuation of pulmonary fibrosis (Figure 3C) as well as upregulated terminal body weight indicative of alleviation of the overall disease severity (Figure 3D). The gene discussed is TSLP; the disease is pulmonary fibrosis.